Orange County — anchored by Irvine and UC Irvine — is one of the most concentrated medtech and biopharma research ecosystems in the United States. Melan works with medical device, biopharma, and health-tech teams across Orange County to structure the research partnerships that bring new therapies and devices to market.
The Orange County Research Partnership Landscape
The University of California, Irvine is a top-10 public university with over $650 million in annual research expenditures. UCI’s School of Medicine, Henry Samueli School of Engineering, and School of Biological Sciences produce research across neuroscience, medtech, cancer biology, and environmental health. The UCI Health system and Chao Family Comprehensive Cancer Center provide clinical research infrastructure. Chapman University and California State University, Fullerton add additional research capacity.
Orange County hosts one of the highest concentrations of medical device and biopharma companies in the US. Edwards Lifesciences (heart valves), Masimo (noninvasive monitoring), B. Braun Medical, MicroVention (Terumo), Smith & Nephew, and Beckman Coulter all maintain headquarters or major R&D operations. The biopharma sector includes Allergan (now AbbVie), Avigen, and dozens of emerging biotechs. The Coulter Foundation and Beall Applied Innovation center support university-industry technology transfer.
Orange County’s partnership landscape is characterized by a high density of small-to-mid-size medtech companies that need structured access to academic research, clinical validation, and university talent pipelines.
What Melan Does for Teams in Orange County
For medtech and device R&D teams: We identify academic partners across UCI’s engineering and medicine programs aligned with your device development priorities — from UCI’s Edwards Lifesciences Center for Advanced Cardiovascular Technology to its Sue & Bill Gross Stem Cell Research Center. We structure sponsored research, materials licensing, and clinical validation partnerships.
For biopharma R&D teams: We connect pharma and biotech companies with UCI’s drug discovery, pharmacology, and clinical trial infrastructure — from early-stage target identification through Phase I–III clinical research.
For UCI and Orange County universities: We help TTOs find corporate partners who can commercialize their medtech discoveries, navigate FDA regulatory requirements in partnership agreements, and structure multi-year research alliances with the region’s device and pharma companies.
FAQ
How does Melan help companies partner with UC Irvine?
We map UCI’s research centers and clinical programs to identify alignment with your medtech or biopharma priorities, then approach UCI’s Innovation and Technology Commercialization office with a pre-structured partnership framework.
What makes Orange County unique for research partnerships?
Orange County combines a top-10 public research university with the highest density of medtech company headquarters in the US. The proximity of device engineers to academic researchers creates partnership velocity that larger, more fragmented regions cannot match.
Does Melan work with Orange County medical device companies?
Yes. We work with Edwards Lifesciences, Masimo, and emerging device companies to structure research partnerships with UCI’s biomedical engineering, cardiovascular, and clinical research programs.
How do I start a research partnership in Orange County?
Contact Melan at themelan.com/contact-us. We discuss your R&D priorities and map the Orange County research ecosystem to identify the right collaborators.
Ready to form a research partnership in Orange County?
Melan helps medtech, biopharma, and health-tech teams across Irvine and Orange County structure successful research collaborations.
